Cambridge, Massachusetts-based Transatomic Power Corporation has just received $2 million from FF Science, part of Founders Fund's $1 billion investment pool targeted at science and engineering-based companies.
Country
China's latest anti-trust probes revive protectionism concerns
China's recent probes into Microsoft Corp and car companies including Audi and Chrysler have rekindled concerns that Beijing may be using an anti-monopoly law to support domestic firms at the expense of foreign companies.
Samsung vs. Apple: Apple is Winning the War?
Samsung and Apple have been battling it out in the smartphone arena for at least three years. The big question is: Who will conquer the world and get dominion in the consumer electronic business?
Memblaze to use $20 million from Series C to fund research and development of new generation flash memory products
Chinese news reports that Beijing based-Memblaze has completed Series C funding with $20 million. Investors include Bertelsmann Asia Investments, Israel's Infinity Group, ZTE Corporation's Ding Xing Fund, and Genertec Investment Managers Ltd.
Retention Science's "retention marketing technology" gets $7 million in Series A
Retention Science managed to raise $7 million in Series A funding, backed by Upfront Ventures, and earlier investors including Baroda Ventures, Forerunner Ventures, Mohr Davidow Ventures as well as so-called angel investors. With the recent funding, the company reportedly plans to hire sales and marketing staff, as well as more data scientists who can demonstrate "retention marketing" beyond retail.
Latest News
European stocks fell on Wednesday while nervous investors took refuge in high-rated bonds as Russia amassed troops on its border with Ukraine, raising concerns among western powers that it could invade.
Seattle-based Juno Therapeutics announced it has closed Series B round of funding with $134 million. The new funding came from previous investors including ARCH Venture Partners, Alaska Permanent Fund, Bezos Expedition, the personal investment company of Amazon founder Jeff Bezos, and Venrock. Also participating in Series B are 10 other mutual funds and healthcare-related funds that wish to remain anonymous.
Vectra Networks managed to raise additional $25 million in its Series C funding from existing investor Accel Partners and other investors, including AME Cloud Ventures, IA Ventures and Khosla Ventures participating in the round, Intel Capital and Juniper Networks, through its Junos Innovation Fund. The new investment will be used to boost sales, marketing efforts as well as engineering.
Metanautix has received $7 million in initial funding from Sequioa Capital, the Stanford University Endowment Fund and Shiva Shivakumar, a former VP of engineering at Google. The company plans to release its first product for general availability before the end of 2014. At present, there are half a dozen beta customers using the software, with the largest being Hewlett-Packard.
Seoul-based Spoqa has raised $3.9 million in Series B funding from Daesung Private Equity Group and Bokwang Investments, and plans to use the investment for expansion in Japan.
Response Genetics recently closed a credit agreement with SWK Funding for a multi-draw loan term of up to $12 million. The creditor has advanced the company $8.5 million, which is due on July 30, 2020, while the rest can be withdrawn once predetermined revenue milestones are reached.
Ariana Grande has recently called it quits with now ex-boyfriend Jai Brooks, and rumors are circulating that she's now going out with collaborator Big Sean.
There is a popular saying that says, "Health is wealth." Another familiar slogan says, "An apple a day makes the doctor go away." So, is Apple really entering the field of medicine and health?
In recent years, there has been much discussion in the business and legal communities about Non-Practicing Entities, a.k.a. patent trolls, and the ills and costs they can often impose on companies large and small.
